Cancers | Free Full-Text | Maximum Tolerated Dose and Anti-Tumor Activity of Intraperitoneal Cantrixil (TRX-E-002-1) in Patients with Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer: Phase I
Tolerability of Carboplatin When Using Rounded Serum Creatinine Values
Carboplatin - wikidoc
Frontiers | A Dose Escalation Study of Trientine Plus Carboplatin and Pegylated Liposomal Doxorubicin in Women With a First Relapse of Epithelial Ovarian, Tubal, and Peritoneal Cancer Within 12 Months After Platinum-Based
Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer | NEJM
Activation of Carboplatin by Carbonate | Chemical Research in Toxicology
Pharmacokinetic Considerations in Oncology | Basicmedical Key
Evaluation of Equations for Carboplatin Dosage | Semantic Scholar
Carboplatin - wikidoc
Pemetrexed / CARBOplatin
Regimen Reference Order
Overestimation of carboplatin doses is avoided by radionuclide GFR measurement | British Journal of Cancer
The optimisation of carboplatin dose in carboplatin, etoposide and bleomycin combination chemotherapy for good prognosis metasta
Carboplatin and Creatinine Have we got it right? - ppt video online download
Treatment schema. *Carboplatin dose decreased to AUC 5.0 in all... | Download Scientific Diagram
Letter comments on: Glomerular filtration rate estimation for carboplatin dosing in patients with gynaecological cancers - ESMO Open
Carboplatin and Vinorelbine with Radiotherapy Non-Small Cell Lung Cancer - COVID 19 Protocol
Regimen Reference Order – GENU – CARBOplatin (prostate)
Carboplatin: Package Insert / Prescribing Information - Drugs.com
Carboplatin and Creatinine Have we got it right? - ppt video online download
Equations used for calculation of eGFR and carboplatin dosing | Download Table
Carboplatin | CancerIndex
Electroretinogram Monitoring of Dose-Dependent Toxicity after Ophthalmic Artery Chemosurgery in Retinoblastoma Eyes: Six Year Review | PLOS ONE
Carboplatin dose calculations for patients with lung cancer: significant dose differences found depending on dosing equation choice | BMC Cancer | Full Text
Carboplatin Dosing in Overweight and Obese Patients: A Single-Center Experience
